申请人:SmithKline Beckman Corporation
公开号:US04529604A1
公开(公告)日:1985-07-16
N,N-Di-(n-propyl)dopamine derivatives having peripheral dopamine receptor agonist activity prepared by synthetic routes known for phenethylamines. The renal vasodilator effect of 3,4-dihydroxy-N,N-di(n-propyl)-phenethylamine is potentiated by the concomitant administration of the .beta.-blocker propranolol.
N,N-二(正丙基)多巴胺衍生物具有外周多巴胺受体激动剂活性,通过已知的苯乙胺合成途径制备。3,4-二羟基-N,N-二(正丙基)-苯乙胺的肾血管扩张作用通过同时给予β受体阻滞剂普萘洛尔而增强。